Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) concluded the trading at $0.58 on Wednesday, February 19 with a fall of -3.85% from its closing price on previous day.
Considering stock’s 52-week price range provides that CDIO hit a high price of $1.86 and saw its price falling to a low level of $0.19 during that period. Over a period of past 1-month, stock came adding 10.46% in its value.
With its current market valuation of $30.51 million, Cardio Diagnostics Holdings Inc is set to declare its quarterly results in March. Analysts are in estimates of -0.06 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -0.36 for current year with estimates of that growing to -0.23 in next year.
Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of 25k. They suggested that in the process company could generate revenue of as low as 25k which could climb up to 25k to hit a high. The average estimate is representing an increase of 370.81% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of 55k in current fiscal year, which will be 222.20% more from revenue generated by the company last year.
In contrast, when we review CDIO stock’s current outlook then short term indicators are assigning it an average of 50% Buy, while medium term indicators are categorizing the stock at an average of 50% Buy. Long term indicators are suggesting an average of 50% Buy for it.
Digging deeper we become aware of the PEG ratio of the CDIO stock which is currently positioned at 0. It further provides that stock’s current price level is 13.11% away from its 20-day simple moving average and is -19.36% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 50.40 while volatility remained at 15.95% over the past week which changes to 16.87% when measuring it over the past month. Beta is valued at 3.56, while measure of average true range or ATR is currently at 0.10.
The percentage of outstanding shares held by the insiders is 9.73% while it is 6.32% for the institutional holders. Subtraction of -36.21% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
